Results
1
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1 companies
Caliway Biopharmaceuticals
Market Cap: NT$154.1b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$997.00
7D
1.7%
1Y
105.1%